グルコサミン市場：タイプ、形態、供給源、用途、流通チャネル別-2025～2030年世界予測

グルコサミン市場は、2023年に8億48万米ドルと評価され、2024年には8億4,171万米ドルに達すると予想され、CAGR 5.28%で成長し、2030年には11億4,762万米ドルになると予測されています。

軟骨の発達に不可欠な天然化合物であるグルコサミンは、関節の健康における役割が広く認識されており、変形性関節症やその他の関節関連疾患の管理を目的としたサプリメントによく使用されています。高齢化社会、アスリート、健康志向の人々の間で筋骨格系の健康に対する意識が高まっていることが、市場の裾野を広げています。グルコサミンの需要を牽引する主要必要性は、関節痛を和らげ、運動能力を向上させる可能性があることであり、医薬品、栄養補助食品、食品サプリメント産業で大きく評価されています。その用途は動物の健康にも及び、ペットの同様の問題を助けるために組み込まれるなど、最終用途の範囲は多岐にわたります。成長に影響を与える主要動向には、予防医療への傾向、サプリメント使用の増加、グルコサミンの利点を裏付ける進行中の調査などがあります。グルコサミンとコンドロイチンやMSMを融合させたコンビネーションサプリメントなどの製剤における革新は、意識と健康支出が上昇傾向にある未開拓の地域市場と同様に、大きな機会をもたらします。グルコサミン製品の有効性に関する懸念、代替療法を含む競合力学、栄養補助食品セグメントにおける規制の精査といった課題も残っています。企業は、持続可能性への懸念を背景に、海産物や貝類を起源とするため変動する原料価格とともに、こうした問題を乗り切らなければならないです。将来の市場拡大は、吸収を高めるための液状化や、ベジタリアン層に対応するためのビーガンまたは合成グルコサミンなど、送達メカニズムの革新によって促進される可能性があります。さらに、科学的な主張を補強するために臨床検査を強化することは、利害関係者が市場での地位を固めるための強力な提言となります。市場全体の情勢は多様で競合が多く、戦略的提携や消費者教育は、市場情勢の課題に対処しながら、市場情勢の潜在的成長力を最大限に活用するための重要な手段となっています。

市場力学：急速に進化するグルコサミン市場の主要市場洞察を公開

グルコサミン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 肥満人口の増加と関節炎患者の増加
  • 骨と関節の健康サプリメントにおけるグルコサミンの使用の増加
  • 症候性変形性膝関節症の治療におけるグルコサミンのニーズの高まり
• 市場抑制要因
  • グルコサミン製品に関する高コスト
• 市場機会
  • 新規グルコサミン製品の上市と承認
  • グルコサミンセグメントにおけるメーカーの研究開発活動への注力
• 市場課題
  • グルコサミンに関連するいくつかの副作用

ポーターのファイブフォース：グルコサミン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、グルコサミン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：グルコサミン市場における外部からの影響の把握

外部マクロ環境要因は、グルコサミン市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：グルコサミン市場における競合情勢の把握

グルコサミン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：グルコサミン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、グルコサミン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：グルコサミン市場における成功への道筋を描く

グルコサミン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肥満人口の増加と関節炎患者数の増加
    • 骨と関節の健康サプリメントにおけるグルコサミンの使用増加
    • 膝の症状のある変形性関節症の治療におけるグルコサミンの必要性の高まり
  • 抑制要因
    • グルコサミン製品に関連する高コスト
  • 機会
    • 新しいグルコサミン製品の発売と承認
    • グルコサミンセグメントにおけるメーカーの研究開発活動への注力
  • 課題
    • グルコサミンに関連するいくつかの副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 グルコサミン市場：タイプ別

• イントロダクション
• グルコサミン塩酸塩
• グルコサミン硫酸カリウム塩化物
• グルコサミン硫酸ナトリウム塩化物
• N-アセチルグルコサミン

第7章 グルコサミン市場：形態別

• イントロダクション
• カプセル
• 液体
• 粉末
• 錠剤

第8章 グルコサミン市場：供給源別

• イントロダクション
• 動物
  • カニ
  • ロブスター
  • エビ
• 植物
  • トウモロコシ
  • キノコ

第9章 グルコサミン市場：用途別

• イントロダクション
• 化粧品
• 栄養補助食品
• 健康食品
• 薬剤
• 獣医

第10章 グルコサミン市場：流通チャネル別

• イントロダクション
• オンラインストア
• 薬局
• 小売店
• スーパーマーケット

第11章 南北アメリカのグルコサミン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋のグルコサミン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのグルコサミン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aden Healthcare
• Andra Medi Pharma India Pvt. Ltd.
• Bio-gen Extracts Pvt. Ltd.
• Captek Softgel International Inc.
• Cargill, Inc.
• Cellmark AB
• Enomark Pharma
• Ethical Naturals Inc.
• Fabrichem, Inc.
• Fermentis Life Sciences
• GlucosaGreen
• Golden Shell Pharmaceutical Co. Ltd.
• Kabir Lifesciences
• Koyo Chemical Co., Ltd.
• Lifecare Neuro Products Limited
• Manus Aktteva Biopharma LLP
• Panvo Organics Pvt Ltd.
• Pax Healthcare
• Schiff Nutrition International Inc.
• SMPNutra
• Spectrum Chemical Manufacturing Corp.
• TSI Health Sciences, Inc.
• United Laboratories, Inc.
• Velnex Medicare
• Wellable Marine BIoTech Holding Limited
• Zhejiang AOXING BIoTechnology Co., Ltd.

LIST OF FIGURES

• FIGURE 1. GLUCOSAMINE MARKET RESEARCH PROCESS
• FIGURE 2. GLUCOSAMINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GLUCOSAMINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GLUCOSAMINE MARKET DYNAMICS
• TABLE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE POTASSIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE SODIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY N-ACETYLGLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GLUCOSAMINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GLUCOSAMINE MARKET SIZE, BY CRAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GLUCOSAMINE MARKET SIZE, BY LOBSTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GLUCOSAMINE MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GLUCOSAMINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GLUCOSAMINE MARKET SIZE, BY CORN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GLUCOSAMINE MARKET SIZE, BY MUSHROOOM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GLUCOSAMINE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTH FOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GLUCOSAMINE MARKET SIZE, BY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL GLUCOSAMINE MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL GLUCOSAMINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL GLUCOSAMINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL GLUCOSAMINE MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL GLUCOSAMINE MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. CANADA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 61. CANADA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 62. CANADA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 63. CANADA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 64. CANADA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 65. CANADA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CANADA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. CHINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 98. CHINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 99. CHINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 100. CHINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 101. CHINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 102. CHINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. CHINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. INDIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 105. INDIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 106. INDIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 107. INDIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 108. INDIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 109. INDIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. INDIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. ITALY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 225. ITALY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 226. ITALY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 227. ITALY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 228. ITALY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 229. ITALY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. ITALY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 252. POLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 253. POLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 254. POLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 255. POLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 256. POLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 257. POLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. POLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 259. QATAR GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 260. QATAR GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 261. QATAR GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 262. QATAR GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 263. QATAR GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 264. QATAR GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. QATAR GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 329. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 330. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023

The Glucosamine Market was valued at USD 800.48 million in 2023, expected to reach USD 841.71 million in 2024, and is projected to grow at a CAGR of 5.28%, to USD 1,147.62 million by 2030.

Glucosamine, a natural compound integral to cartilage development, is widely recognized for its role in joint health and often sourced for supplements aimed at managing osteoarthritis and other joint-related ailments. The growing awareness of musculoskeletal health among aging populations, athletes, and health-conscious individuals has expanded the market's reach. A major necessity driving glucosamine demand is its potential to alleviate joint pain and improve mobility, largely appreciated in pharmaceutical, nutraceutical, and food supplements industries. Its application extends to animal health, where it's incorporated to aid similar issues in pets, marking a varied end-use scope. Key factors influencing growth include the trend towards preventive healthcare, an increase in supplement usage, and ongoing research corroborating glucosamine's benefits. Innovations in formulation, such as combination supplements merging glucosamine with chondroitin or MSM, pose substantial opportunities, as do unexplored regional markets where awareness and health expenditure are on the rise. Nevertheless, challenges persist: concerns regarding the efficacy of glucosamine products, competitive dynamics involving alternative therapies, and regulatory scrutiny in the nutraceutical space. Companies must navigate these issues alongside fluctuating raw material prices due to its marine and shellfish origins, against the backdrop of sustainability concerns. Future market expansion can be fueled by innovation in delivery mechanisms, such as liquid form for enhanced absorption and vegan or synthetic glucosamine to cater to vegetarian demographics. Additionally, enhancing clinical trials to reinforce scientific claims serves as a strong recommendation for stakeholders to consolidate market positions. The overall market landscape is diverse and competitive, with strategic alliances and consumer education emerging as critical tools to leverage glucosamine's full growth potential while addressing prevailing market challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucosamine Market

The Glucosamine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing obese population coupled with increasing number of arthritis cases
  • Increasing use of glucosamine in bone and joint health supplements
  • Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
• Market Restraints
  • High cost related to glucosamine products
• Market Opportunities
  • Launch and approval of novel glucosamine products
  • Focus of manufacturers on R&D activities in the field of glucosamine
• Market Challenges
  • Several side effects associated with glucosamine

Porter's Five Forces: A Strategic Tool for Navigating the Glucosamine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucosamine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucosamine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucosamine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucosamine Market

A detailed market share analysis in the Glucosamine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucosamine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucosamine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucosamine Market

A strategic analysis of the Glucosamine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucosamine Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Andra Medi Pharma India Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Captek Softgel International Inc., Cargill, Inc., Cellmark AB, Enomark Pharma, Ethical Naturals Inc., Fabrichem, Inc., Fermentis Life Sciences, GlucosaGreen, Golden Shell Pharmaceutical Co. Ltd., Kabir Lifesciences, Koyo Chemical Co., Ltd., Lifecare Neuro Products Limited, Manus Aktteva Biopharma LLP, Panvo Organics Pvt Ltd., Pax Healthcare, Schiff Nutrition International Inc., SMPNutra, Spectrum Chemical Manufacturing Corp., TSI Health Sciences, Inc., United Laboratories, Inc., Velnex Medicare, Wellable Marine Biotech Holding Limited, and Zhejiang AOXING Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Glucosamine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Types, market is studied across Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride, and N-Acetylglucosamine.
• Based on Form, market is studied across Capsules, Liquid, Powder, and Tablets.
• Based on Source, market is studied across Animal and Plant. The Animal is further studied across Crab, Lobster, and Shrimp. The Plant is further studied across Corn and Mushrooom.
• Based on Application, market is studied across Cosmetics, Dietary Supplements, Health Food, Medicine, and Veterinary.
• Based on Distribution Channel, market is studied across Online Stores, Pharmacies, Retail Stores, and Supermarkets.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing obese population coupled with increasing number of arthritis cases
    • 5.1.1.2. Increasing use of glucosamine in bone and joint health supplements
    • 5.1.1.3. Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
  • 5.1.2. Restraints
    • 5.1.2.1. High cost related to glucosamine products
  • 5.1.3. Opportunities
    • 5.1.3.1. Launch and approval of novel glucosamine products
    • 5.1.3.2. Focus of manufacturers on R&D activities in the field of glucosamine
  • 5.1.4. Challenges
    • 5.1.4.1. Several side effects associated with glucosamine
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Glucosamine Market, by Types

• 6.1. Introduction
• 6.2. Glucosamine Hydrochloride
• 6.3. Glucosamine Sulfate Potassium Chloride
• 6.4. Glucosamine Sulfate Sodium Chloride
• 6.5. N-Acetylglucosamine

7. Glucosamine Market, by Form

• 7.1. Introduction
• 7.2. Capsules
• 7.3. Liquid
• 7.4. Powder
• 7.5. Tablets

8. Glucosamine Market, by Source

• 8.1. Introduction
• 8.2. Animal
  • 8.2.1. Crab
  • 8.2.2. Lobster
  • 8.2.3. Shrimp
• 8.3. Plant
  • 8.3.1. Corn
  • 8.3.2. Mushrooom

9. Glucosamine Market, by Application

• 9.1. Introduction
• 9.2. Cosmetics
• 9.3. Dietary Supplements
• 9.4. Health Food
• 9.5. Medicine
• 9.6. Veterinary

10. Glucosamine Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Online Stores
• 10.3. Pharmacies
• 10.4. Retail Stores
• 10.5. Supermarkets

11. Americas Glucosamine Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Glucosamine Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Glucosamine Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aden Healthcare
• 2. Andra Medi Pharma India Pvt. Ltd.
• 3. Bio-gen Extracts Pvt. Ltd.
• 4. Captek Softgel International Inc.
• 5. Cargill, Inc.
• 6. Cellmark AB
• 7. Enomark Pharma
• 8. Ethical Naturals Inc.
• 9. Fabrichem, Inc.
• 10. Fermentis Life Sciences
• 11. GlucosaGreen
• 12. Golden Shell Pharmaceutical Co. Ltd.
• 13. Kabir Lifesciences
• 14. Koyo Chemical Co., Ltd.
• 15. Lifecare Neuro Products Limited
• 16. Manus Aktteva Biopharma LLP
• 17. Panvo Organics Pvt Ltd.
• 18. Pax Healthcare
• 19. Schiff Nutrition International Inc.
• 20. SMPNutra
• 21. Spectrum Chemical Manufacturing Corp.
• 22. TSI Health Sciences, Inc.
• 23. United Laboratories, Inc.
• 24. Velnex Medicare
• 25. Wellable Marine Biotech Holding Limited
• 26. Zhejiang AOXING Biotechnology Co., Ltd.